Identification of a Glycosylation‐Related Gene Prognostic Signature for Non–Small Cell Lung Cancer
The Journal of Gene Medicine · 2026
DOI: 10.1002/jgm.70121 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Gene Medicine, 2026. Verfasst von Qingtao Zhao und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Hebei General Hospital, Shijiazhuang, Hebei, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Gene Expression Regulation, Neoplastic, Biomarkers, Tumor. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Key Research and Development Program of Hebei Province, Hebei Provincial Key Research Projects.
Abstract (Originalsprache)
Purpose
A prognostic signature for non–small cell lung cancer (NSCLC) was developed through identification and integration of glycosylation‐related genes (GRGs).
Methods
TCGA RNA‐seq data for LUAD and LUSC were analyzed. GRGs were intersected with differentially expressed genes; prognostic GRGs were selected via Cox and LASSO regression to construct a risk model. The immune microenvironment and immunotherapy responses were compared between risk groups. An miRNA–mRNA–transcription factor (TF) network was built and potential drugs were predicted. ADAMTS15 expression was verified by RT‐qPCR in NSCLC tissues and cell lines; functional assays (CCK‐8, wound healing, Transwell) were performed after ADAMTS15 knockdown in A549 (LUAD) and NCI‐H520 (LUSC) cells.
Results
A total of 134 differentially expressed GRGs were identified. Ten genes (ADAMTS15, PCSK9, MUC2, B3GNT3, etc.) were selected for the prognostic model, which functioned as an independent prognostic factor. High‐risk patients showed poorer immunotherapy response. The regulatory network included 30 TFs and 142 miRNAs, with 107 drug–target pairs predicted. ADAMTS15 was elevated in NSCLC; its knockdown inhibited proliferation, migration, and invasion in both LUAD and LUSC cell models.
Conclusion
A 10‐gene prognostic signature derived from GRGs was identified. Functional validation affirmed ADAMTS15's tumor‐promoting role, offering insights for NSCLC prognosis and targeted therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Surgery, Hebei General Hospital, Shijiazhuang, Hebei, China.
ORCID-Profile: Qingtao Zhao, Xiaopeng Zhang, Guochen Duan
Förderung
- Key Research and Development Program of Hebei Province
- Hebei Provincial Key Research Projects
Zitieren
APA
Zhao, Q., Zhang, X., & Duan, G. (2026). Identification of a Glycosylation‐Related Gene Prognostic Signature for Non–Small Cell Lung Cancer. The Journal of Gene Medicine. https://doi.org/10.1002/jgm.70121
Vancouver
Zhao Q, Zhang X, Duan G. Identification of a Glycosylation‐Related Gene Prognostic Signature for Non–Small Cell Lung Cancer. The Journal of Gene Medicine. 2026. doi:10.1002/jgm.70121
BibTeX
@article{Zhao2026,
author = {Zhao, Qingtao and Zhang, Xiaopeng and Duan, Guochen},
title = {Identification of a Glycosylation‐Related Gene Prognostic Signature for Non–Small Cell Lung Cancer},
journal = {The Journal of Gene Medicine},
year = {2026},
doi = {10.1002/jgm.70121}
}
EUVIMED